AbbVie
ABBV
#27
Rank
NZ$658.72 B
Marketcap
$373.14
Share price
1.96%
Change (1 day)
27.58%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : NZ$235.27 Billion

According to AbbVie's latest financial reports the company's total liabilities are NZ$235.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$196.57 B2.71%
2022-12-31NZ$191.39 B-0.28%
2021-12-31NZ$191.92 B0.74%
2020-12-31NZ$190.52 B31.89%
2019-12-31NZ$144.45 B42.92%
2018-12-31NZ$101.07 B9.28%
2017-12-31NZ$92.49 B4.24%
2016-12-31NZ$88.73 B23.67%
2015-12-31NZ$71.74 B118.13%
2014-12-31NZ$32.89 B9.4%
2013-12-31NZ$30.06 B4.6%
2012-12-31NZ$28.74 B195.59%
2011-12-31NZ$9.72 B38.11%
2010-12-31NZ$7.04 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$226.56 B-3.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$136.05 B-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$115.03 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$153.45 B-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$64.50 B-72.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.23 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.54 B-54.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$112.75 B-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$2.01 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA